BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 491194)

  • 1. [L-DOPA and dopamine loading test].
    Kato Y
    Nihon Rinsho; 1979 Jun; Suppl():2481-2. PubMed ID: 491194
    [No Abstract]   [Full Text] [Related]  

  • 2. [L-dopa and dopamine loading test].
    Azuma K; Irahara M; Aono T
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():252-5. PubMed ID: 9172519
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopaminergic regulation of growth hormone (GH) secretion in normal man: correlation of L-dopa and dopamine levels with the GH response.
    Bansal S; Lee LA; Woolf PD
    J Clin Endocrinol Metab; 1981 Aug; 53(2):301-6. PubMed ID: 7251816
    [No Abstract]   [Full Text] [Related]  

  • 4. Cimetidine and L-dopa in the control of prolactin secretion in man.
    Pontiroli AE; Pellicciotta G; Alberetto M; De Pasqua A; Girardi AM; Pozza G
    Horm Metab Res; 1979 Mar; 11(3):257-8. PubMed ID: 447211
    [No Abstract]   [Full Text] [Related]  

  • 5. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
    Vasil'ev VN
    Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
    Ogawa A; Kanazawa M; Takayanagi M; Kitani Y; Shintaku H; Kohno Y
    Brain Dev; 2008 Jan; 30(1):82-5. PubMed ID: 17590551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of dopamine synthesis in human brain using positron emission tomography with L-[beta-11C]DOPA.
    Ito H; Ota M; Ikoma Y; Seki C; Yasuno F; Takano A; Maeda J; Nakao R; Suzuki K; Suhara T
    Nucl Med Commun; 2006 Sep; 27(9):723-31. PubMed ID: 16894327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.
    Lissoni P; Malugani F; Casu M; Bukovec R; Egardi R; Bordin V; Fumagalli E; Mengo S; Gardani G
    Neuro Endocrinol Lett; 2002 Feb; 23(1):61-3. PubMed ID: 11880864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of l-dopa administration on the prolactin levels in short-stature subjects].
    Saggese G; Cesaretti G; Carlotti C; Cioni C; Bracaloni C
    Minerva Pediatr; 1992 Mar; 44(3):73-8. PubMed ID: 1518496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The L-dopa test in Parkinson's disease].
    Esteguy M; Bonnet AM; Kefalos J; Lhermitte F; Agid Y
    Rev Neurol (Paris); 1985; 141(5):413-5. PubMed ID: 4048732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prolactin and cancer of the breast. II. Prediction of the response to hormone treatment. The Minton test].
    Cueto Ladrón de Guevara J; García Puche JL; Pedraza V
    Rev Esp Oncol; 1985; 32(3):459-70. PubMed ID: 3870537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration.
    Fujita M; Shimizu T
    Bull Osaka Med Sch; 1986 Oct; 32(2):73-84. PubMed ID: 3122863
    [No Abstract]   [Full Text] [Related]  

  • 14. [L-DOPA loading test].
    Shizume K; Kozuka N
    Nihon Rinsho; 1979 Jun; Suppl():2469-70. PubMed ID: 491189
    [No Abstract]   [Full Text] [Related]  

  • 15. Dissociation of growth hormone and prolactin response to levodopa during pyridoxine administration.
    Delitala G; Masala A
    Biomedicine; 1977 Jul; 27(6):219-22. PubMed ID: 20170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes induced with L-dopa in the serum levels of prolactin and somatotropin in the diagnosis of amenorrhea-galactorrhea].
    Campagnoli C; Fessia L; Gilli V; Pagliardini S; Peris C; Richetta R; Rustichelli S
    Minerva Ginecol; 1978 Mar; 30(3):135-8. PubMed ID: 566402
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma prolactin response to L-dopa TRH and metaclopramide in thyrotoxicosis.
    Delitala G; Masala A; Alagna S; Devilla L
    Biomedicine; 1976 Jul; 25(5):173-6. PubMed ID: 1000028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma testosterone during bicycle ergometer exercise without and after L-dopa pretreatment.
    Jezová-Repceková D; Vigas M; Mikulaj L; Jurcovicová J
    Endocrinol Exp; 1982 Mar; 16(1):3-8. PubMed ID: 6978249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: The importance of intracerebral decarboxylation of L-DOPA in the suppression of prolactin secretion.
    Franks S; Lawton NF; Marshall NJ
    J Physiol; 1975 Nov; 252(2):52P-54P. PubMed ID: 1206543
    [No Abstract]   [Full Text] [Related]  

  • 20. [The L-DOPA test in patients with obsessive fear neurosis].
    Vasil'ev VN; Chugunov VS; Derbeneva LM; Eremeev MS
    Vopr Med Khim; 1988; 34(1):115-20. PubMed ID: 3369120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.